Sphere Fluidics
Booth 312
August 19-22, 2024
Sheraton Boston
Boston, MA, USA
We eagerly anticipate connecting with you at the Bioprocessing Summit, where thought leaders and pioneers in bioprocess R&D, scale-up, quality, and analytics are brought together. Join us at Booth 312.
Explore how our microfluidic picodroplet technology platforms can accelerate your workflows, from Cell Line Development to other applications. Let’s discuss how we can streamline your processes and enhance efficiency.
Join Simona Preiksaite for a Poster Showcase
Learn more about picodroplet technology
Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process
Simona Preiksaite
August 19, 17:30-18.30
Poster #A45, Poster Session A
August 20th, you have three opportunities:
- 10:00-10:45
- 13:30-14:10
- 15:45-16:30
Simona Preiksaite, Senior Field Application Scientist, Sphere Fluidics
PRESENTATION DETAILS
Although antibody therapeutics dominate drug development, prolonged workflows and increasing costs during their discovery and development hinder their success. Cyto-Mine® by Sphere Fluidics, utilizes picodroplet technology, microfluidics and imaging, to address these obstacles in Antibody Discovery (AbD) and Cell Line Development (CLD), expediting therapeutic development.
Cyto-Mine® offers significant advantages in the number of cells that can be processed, cost per run, and the speed with which projects can be completed. Sphere Fluidics has developed a 2nd generation Cyto-Mine® instrument that enables the use of more fluors, multiplexed assays, and a broader range of applications.
Early applications of the new Cyto-Mine® platform will enable cell isolation based on cell surface markers, viability, and titer of secreted proteins. Moreover, in combination with re-injection-based workflows, it will facilitate complex assays like combining cell types in a single droplet (crucial for binding assessment, cytotoxic assays, and advancing antibody development).
About Simona Preiksaita
Simona has a background in cell line development and has extensive technical support experience. She is driven to help our customers to tackle challenges when running their experiments and lead them to new discoveries by providing bespoke support.
View our latest poster presentation featuring Cyto-Mine®Chroma
Highlights Include:
Faster project completion
Multiplexing capabilities
Rapid identification and isolation of rare cells
Assurance of monoclonality in selected cells
Visit the event website to register now
